Millennium Beats IPXpharma's Cancer Drug Patent Suit
A Tennessee federal judge on Tuesday tossed IPXpharma's infringement suit against Millennium Pharmaceuticals Inc. over its cancer drug Velcade, ruling IPX didn't have the right to sue for past infringement....To view the full article, register now.
Already a subscriber? Click here to view full article